The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hirano, T.
Right arrow Articles by Onoue, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hirano, T.
Right arrow Articles by Onoue, K.

The Journal of Immunology, Vol 132, Issue 1 229-234, Copyright © 1984 by American Association of Immunologists


ARTICLES

Human helper T cell factor(s). III. Characterization of B cell differentiation factor I (BCDF I)

T Hirano, T Teranishi and K Onoue

Staphylococcus aureus Cowan I (SAC) induced proliferation of human B cells but did not lead the cells to differentiate to immunoglobulin (Ig)-producing cells. The differentiation of SAC-stimulated B cells to IgG-producing cells was totally dependent on T cells or T cell factor, designated B cell differentiation factor I (BCDF I). BCDF I exerted its effect on B cells between 48 and 72 hr after the initiation of the culture, at which time the 3H-TdR uptake of SAC-stimulated B cells had already reached a maximal level. Highly purified human IL 2 did not induce the differentiation of SAC-stimulated B cells for IgG-producing cells. Therefore the differentiation-inducing ability of BCDF I was not due to the residual T cells in a purified B cell preparation, which might have been activated by a possible contamination of IL 2 in the BCDF I preparation. The apparent m.w. of BCDF I was estimated to be 20,000 by gel filtration. Isoelectric focusing analysis showed that its activity was distributed in three fractions corresponding to pI 6.5, 7.0, and 8.0. In contrast, BCDF II, which induced IgG production in an Epstein Barr virus-transformed B lymphoblastoid cell line, was focused in the fractions with pI range of 4.8 to 5.5. Thus there are at least two different kinds of BCDF for human B cells, designated here as BCDF I and BCDF II.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1984 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1984 by The American Association of Immunologists, Inc. All rights reserved.